MRMD
Price
$0.11
Change
-$0.02 (-15.38%)
Updated
Aug 15 closing price
Capitalization
43.15M
80 days until earnings call
TSNDF
Price
$0.83
Change
+$0.01 (+1.22%)
Updated
Aug 15 closing price
Capitalization
264.96M
93 days until earnings call
Interact to see
Advertisement

MRMD vs TSNDF

Header iconMRMD vs TSNDF Comparison
Open Charts MRMD vs TSNDFBanner chart's image
MariMed
Price$0.11
Change-$0.02 (-15.38%)
Volume$2.79M
Capitalization43.15M
TerrAscend
Price$0.83
Change+$0.01 (+1.22%)
Volume$975.2K
Capitalization264.96M
MRMD vs TSNDF Comparison Chart in %
Loading...
MRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRMD vs. TSNDF commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRMD is a Hold and TSNDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (MRMD: $0.11 vs. TSNDF: $0.83)
Brand notoriety: MRMD and TSNDF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: MRMD: 414% vs. TSNDF: 129%
Market capitalization -- MRMD: $43.15M vs. TSNDF: $264.96M
MRMD [@Pharmaceuticals: Generic] is valued at $43.15M. TSNDF’s [@Pharmaceuticals: Generic] market capitalization is $264.96M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRMD’s FA Score shows that 0 FA rating(s) are green whileTSNDF’s FA Score has 1 green FA rating(s).

  • MRMD’s FA Score: 0 green, 5 red.
  • TSNDF’s FA Score: 1 green, 4 red.
According to our system of comparison, TSNDF is a better buy in the long-term than MRMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRMD’s TA Score shows that 5 TA indicator(s) are bullish while TSNDF’s TA Score has 2 bullish TA indicator(s).

  • MRMD’s TA Score: 5 bullish, 2 bearish.
  • TSNDF’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, MRMD is a better buy in the short-term than TSNDF.

Price Growth

MRMD (@Pharmaceuticals: Generic) experienced а +12.82% price change this week, while TSNDF (@Pharmaceuticals: Generic) price change was +49.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Reported Earning Dates

MRMD is expected to report earnings on Nov 05, 2025.

TSNDF is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSNDF($265M) has a higher market cap than MRMD($43.2M). TSNDF YTD gains are higher at: 27.554 vs. MRMD (-5.009). MRMD has higher annual earnings (EBITDA): 11.4M vs. TSNDF (9.91M). TSNDF has more cash in the bank: 30.2M vs. MRMD (7M). MRMD has less debt than TSNDF: MRMD (87.5M) vs TSNDF (246M). TSNDF has higher revenues than MRMD: TSNDF (297M) vs MRMD (158M).
MRMDTSNDFMRMD / TSNDF
Capitalization43.2M265M16%
EBITDA11.4M9.91M115%
Gain YTD-5.00927.554-18%
P/E RatioN/A82.91-
Revenue158M297M53%
Total Cash7M30.2M23%
Total Debt87.5M246M36%
FUNDAMENTALS RATINGS
MRMD vs TSNDF: Fundamental Ratings
MRMD
TSNDF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9596
PRICE GROWTH RATING
1..100
5335
P/E GROWTH RATING
1..100
978
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRMD's Valuation (59) in the null industry is in the same range as TSNDF (79). This means that MRMD’s stock grew similarly to TSNDF’s over the last 12 months.

MRMD's Profit vs Risk Rating (100) in the null industry is in the same range as TSNDF (100). This means that MRMD’s stock grew similarly to TSNDF’s over the last 12 months.

MRMD's SMR Rating (95) in the null industry is in the same range as TSNDF (96). This means that MRMD’s stock grew similarly to TSNDF’s over the last 12 months.

TSNDF's Price Growth Rating (35) in the null industry is in the same range as MRMD (53). This means that TSNDF’s stock grew similarly to MRMD’s over the last 12 months.

TSNDF's P/E Growth Rating (8) in the null industry is significantly better than the same rating for MRMD (97). This means that TSNDF’s stock grew significantly faster than MRMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRMDTSNDF
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
87%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
Bearish Trend 18 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
MRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ORSAX15.270.03
+0.20%
North Square Dynamic Sm Cp A
MGFNX9.64-0.01
-0.10%
MassMutual Global R3
PMYCX43.91-0.14
-0.32%
Putnam Core Equity Fund C
VRKSX11.25-0.04
-0.35%
Virtus KAR Small-Mid Cap Growth R6
CPOCX18.83-0.08
-0.42%
Morgan Stanley Insight L

MRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRMD has been loosely correlated with TSNDF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MRMD jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRMD
1D Price
Change %
MRMD100%
-15.38%
TSNDF - MRMD
45%
Loosely correlated
+1.10%
JUSHF - MRMD
43%
Loosely correlated
-10.65%
TCNNF - MRMD
41%
Loosely correlated
-7.35%
CRLBF - MRMD
40%
Loosely correlated
-1.25%
ACB - MRMD
39%
Loosely correlated
-5.75%
More

TSNDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSNDF has been closely correlated with GTBIF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TSNDF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSNDF
1D Price
Change %
TSNDF100%
+1.10%
GTBIF - TSNDF
78%
Closely correlated
-12.40%
CRLBF - TSNDF
76%
Closely correlated
-1.25%
TCNNF - TSNDF
76%
Closely correlated
-7.35%
CURLF - TSNDF
74%
Closely correlated
-9.48%
VRNOF - TSNDF
74%
Closely correlated
-19.33%
More